{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:35:02Z","timestamp":1778204102507,"version":"3.51.4"},"reference-count":15,"publisher":"Hindawi Limited","issue":"8","license":[{"start":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T00:00:00Z","timestamp":1484611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T00:00:00Z","timestamp":1484611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Diabetes"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1111\/pedi.12486","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T07:38:48Z","timestamp":1484638728000},"page":"835-838","source":"Crossref","is-referenced-by-count":9,"title":["Diagnostic and management challenges from childhood, puberty through to transition in severe insulin resistance due to insulin receptor mutations"],"prefix":"10.1155","volume":"18","author":[{"given":"Christina","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Paediatric Endocrinology and Diabetes, Bristol Royal Hospital for Children; University Hospitals Bristol NHS Foundation Trust; Bristol UK"},{"name":"Department of Paediatric Endocrinology and Diabetes; St Georges Hospital; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine P.","family":"Burren","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology and Diabetes, Bristol Royal Hospital for Children; University Hospitals Bristol NHS Foundation Trust; Bristol UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2017,1,17]]},"reference":[{"key":"10.1111\/pedi.12486-BIB0001|pedi12486-cit-0001","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1530\/EJE-13-0327","article-title":"Genetics in endocrinology: genetic forms of severe insulin resistance: what endocrinologists should know","volume":"169","author":"Parker","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/pedi.12486-BIB0002|pedi12486-cit-0002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/pedi.12192","article-title":"The diagnosis and management of monogenic diabetes in children and adolescents","volume":"15","author":"Rubio-Cabezas","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1111\/pedi.12486-BIB0003|pedi12486-cit-0003","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000111067","article-title":"A clinical approach to severe insulin resistance","volume":"11","author":"Savage","year":"2007","journal-title":"Endocr Dev"},{"key":"10.1111\/pedi.12486-BIB0004|pedi12486-cit-0004","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2265.2010.03810.x","article-title":"What is the best management strategy for patients with severe insulin resistance?","volume":"73","author":"Semple","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/pedi.12486-BIB0005|pedi12486-cit-0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2251-6581-11-17","article-title":"The importance of hypoglycemia in diabetic patients","volume":"11","author":"Shafiee","year":"2012","journal-title":"J Diabetes Metab Disord"},{"key":"10.1111\/pedi.12486-BIB0006|pedi12486-cit-0006","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/er.2010-0020","article-title":"Genetic syndromes of severe insulin resistance","volume":"32","author":"Semple","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1111\/pedi.12486-BIB0007|pedi12486-cit-0007","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beem.2011.09.003","article-title":"Metabolic insights from extreme human insulin resistance phenotypes","volume":"26","author":"Stears","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1111\/pedi.12486-BIB0008|pedi12486-cit-0008","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00125-012-2598-x","article-title":"Adiponectin: mechanistic insights and clinical implications","volume":"55","author":"Turer","year":"2012","journal-title":"Diabetologia"},{"key":"10.1111\/pedi.12486-BIB0009|pedi12486-cit-0009","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1210\/jc.2006-0166","article-title":"Elevated plasma adiponectin in humans with genetically defective insulin receptors","volume":"91","author":"Semple","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/pedi.12486-BIB0010|pedi12486-cit-0010","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/dc07-2194","article-title":"Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance","volume":"31","author":"Semple","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1111\/pedi.12486-BIB0011|pedi12486-cit-0011","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.biochi.2012.01.021","article-title":"Adiponectin and leptin in human severe insulin resistance-diagnostic utility and biological insights","volume":"94","author":"Groeneveld","year":"2012","journal-title":"Biochimie"},{"key":"10.1111\/pedi.12486-BIB0012|pedi12486-cit-0012","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-2796.2001.00898.x","article-title":"Rosiglitazone treatment of patients with extreme insulin resistance and diabetes mellitus due to insulin receptor mutations has no effects on glucose and lipid metabolism","volume":"250","author":"Vestergaard","year":"2001","journal-title":"J Intern Med"},{"key":"10.1111\/pedi.12486-BIB0013|pedi12486-cit-0013","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2337\/dc05-1249","article-title":"A patient with extreme insulin resistance syndrome treated with pioglitazone","volume":"29","author":"Hattori","year":"2006","journal-title":"Diabetes Care"},{"issue":"Suppl","key":"10.1111\/pedi.12486-BIB0014|pedi12486-cit-0014","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1530\/EJE-07-0271","article-title":"IGF-I treatment of insulin resistance","volume":"157","author":"McDonald","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/pedi.12486-BIB0015|pedi12486-cit-0015","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1210\/jc.2009-2088","article-title":"Treatment with recombinant human insulin-like growth factor (rhIGF)-I\/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance","volume":"95","author":"Regan","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pediatric Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpedi.12486","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/pedi.12486\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:09:39Z","timestamp":1671818979000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pedi.12486"}},"subtitle":["WEI AND BURREN"],"short-title":[],"issued":{"date-parts":[[2017,1,17]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,12]]}},"URL":"https:\/\/doi.org\/10.1111\/pedi.12486","archive":["Portico"],"relation":{},"ISSN":["1399-543X"],"issn-type":[{"value":"1399-543X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1,17]]}}}